The history of the development of knowledge of myasthenia gravis is reviewed. Clinical
profiles of the immune and non-immune mediated forms of myasthenia are discussed. The …

Myasthenia gravis is discussed with reference to recent immunologic findings,
improvements in diagnostic procedure, and therapy. Myasthenic reactions can be produced …

The vast strides in terms of pathophysiologic understanding which have been made in the
past 25 years of research in myasthenia gravis are remarkable. This period of time has also …

The first case of myasthenia gravis (MG) was described in 1672. Treatment of MG was
negligible until Mary Walker's seminal observation in 1934 of improvement with …

Myasthenia gravis is a chronic disease characterized by a fluctuating weakness of voluntary
muscle, with a preference for the muscles innervated by cranial nerves. The …

The first report of an association between myasthenia gravis (MG) and the thymus gland was
in 1901. Although the underlying mechanisms are uncertain, thymic abnormalities are …

The relationship between the thymus and the pathogenesis of myasthenia gravis is
reviewed. Ten cases of myasthenia gravis who underwent thymectomy at the American …

Much of the improvement in the treatment of myasthenia gravis (MG) over the past 125 years
can be attributed to the effectiveness of general medical measures such as advances in …

Progress in the study of myasthenia gravis has expanded our view of the pathogenesis of
the disease. The significance of a number of theoretical investigations has received …

Publisher Summary This chapter discusses the clinical aspects of myasthenia gravis (MG).
MG is an autoimmune disorder of neuromuscular transmission involving the production of …